European Journal of Pharmacology

Titel Veröffentlichungsdatum Sprache Zitate
Effects of some antidepressant drugs on the depletion of intraneuronal brain catecholamine stores caused by 4,α-dimethyl-meta-tyramine1969/03/01English298
Recent advances in the study on capsaicinoids and capsinoids2011/01/01English295
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP32261994/12/01English294
3H-spiroperidol labels dopamine receptors in pituitary and brain1977/12/01English293
Central dopaminergic neurons: Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid1976/03/01English291
Presynaptic 5-HT autoreceptors on serotonergic cell bodies and/or dendrites but not terminals are of the 5-HT1A subtype1985/07/01English291
Cognitive impairment in major depression2010/01/01English290
Distribution of thyroptropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry1975/12/01English290
In vivo measurement of extracellular dopamine and DOPAC in rat striatum after various dopamine-releasing drugs implications for the origin of extracellular DOPAC1988/04/01English289
Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neurons1979/11/01English282
The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-κB inhibition2010/12/01English278
Bicuculline-insensitive gaba receptors on peripheral autonomic nerve terminals1981/04/01English277
Glucose metabolism and insulin receptor signal transduction in Alzheimer disease2004/04/01English276
Central and peripheral antialgesic action of aspirin-like drugs1978/12/01English270
Alzheimer's disease: Recent treatment strategies2020/11/01English266
Adenosine decreases aspartate and glutamate release from rat hippocampal slices1984/09/01English266
Naloxone as a GABA antagonist: Evidence from iontophoretic, receptor binding and convulsant studies1978/01/01English262
Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors1986/11/01English262
The use of the slowly degradable analog, α,β-methylene ATP, to produce desensitisation of the P2-purinoceptor: Effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder1982/12/01English261
The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action1989/08/01English257
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats2008/12/01English257
ICI 174864: A highly selective antagonist for the opioid Δ-receptor1984/01/01English257
The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain1986/08/01English255
Glucose transporter expression in the central nervous system: relationship to synaptic function2004/04/01English247
Central CRH system in depression and anxiety — Evidence from clinical studies with CRH1 receptor antagonists2008/04/01English246
Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue1969/09/01English246
Attenuation of endothelium-dependent relaxation in aorta from diabetic rats1986/12/01English245
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice2008/03/01English245
Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics2006/09/01English244
Studies on behavioral and biochemical changes in rats after lesion of midbrain raphé1968/11/01English243